2010-11-23 00:00:00,Gilead Submits New Drug Application To FDA For Regimen Of Truvada And TMC278 For HIV
2010-12-22 00:00:00,Gilead Terminates Phase III Clinical Trial Of Ambrisentan In Patients With Idiopathic Pulmonary Fibrosis
2011-02-10 00:00:00,Gilead Refiles New Drug Application With FDA For Regimen of Truvada
2011-02-22 00:00:00,Gilead To Acquire Calistoga Pharmaceuticals For Million
2011-06-28 00:00:00,Gilead Announces Agreement With Tibotec Pharmaceuticals To Develop And Commercialize New Combination Of Cobicistat And Prezista
2011-07-12 00:00:00,Ranbaxy Laboratories Limited Announces Licensing Agreement With Gilead Inc
2011-09-20 00:00:00,JAPAN TOBACCO Announces Result of Phase 3 Clinical Trial of by Gilead Inc
2011-10-26 00:00:00,Squibb And Gilead Announces Licensing Agreement For Development And Commercialization Of New Combination Pill
2011-10-27 00:00:00,Gilead Raises Lower End Of Prior FY 2011 Product Sales Call
2011-10-28 00:00:00,JAPAN TOBACCO Announces Filing of NDA for
2012-01-12 00:00:00,Gilead Completes Tender Offer for All Outstanding Shares Of
2012-02-02 00:00:00,Gilead Issues FY 2012 Product Sales Call
2012-07-16 00:00:00,Food and Drug Administration Approves Gilead Truvada for Reducing Risk of Acquiring HIV
2012-07-19 00:00:00,Electronics For Announces Sale Agreement With Gilead Sciences
2012-09-12 00:00:00,Gilead Sciences Inc Reaffirms FY 2012 Revenue Call
2012-10-18 00:00:00,Gilead Sciences Investment Weekly Ratings Changes
2012-10-23 00:00:00,Gilead Sciences Inc Raises FY 2012 Product Sales Call
2012-11-02 00:00:00,Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter
2012-11-07 00:00:00,Insiders Sold These Stocks on
